Although the CDAHFD model does not induce obesity or hyperglycemia, liver weight was increased in both males and females independent of myeloid AMPK, an effect normalized by 250 mpk metformin treatment (Fig. 1C, I). The gene discussed is PRKAA2; the disease is obesity due to melanocortin 4 receptor deficiency.